Precision medicine
Personalized Holistic Oncology Solution
Step into the future of cancer care with a transformative approach that blends precision diagnostics, personalized therapeutics, and integrative wellness. At the heart of our solution is an advanced in vitro organoid-based assay that recreates patient-specific tumour biology to test drug responses with unmatched accuracy. Paired with comprehensive genomic profiling through leading NGS platforms, we decode the molecular blueprint of each cancer to guide targeted treatment strategies.
Methodology Pillars
Precision Diagnostics
Utilizing high-throughput sequencing and advanced genomic profiling to identify actionable molecular targets with absolute precision.
Personalized Therapeutics
Mapping drug responses through patient-specific organoid assays to select the most effective treatment regimens for individual tumor biology.
Integrative Wellness
A holistic approach that integrates precision medical insights with supportive care to optimize overall health outcomes and patient quality of life.
Three Tests. One Mission.
Total Precision.
In Vitro Organoid-Based Assays
Our organoid platforms recreate key features of patient‑specific tumor biology with high fidelity. By cultivating 3D cell structures derived from clinical samples, we enable ex vivo drug‑response assessments that provide an additional layer of functional insight. These data can help inform discussions on potential therapeutic options by highlighting how the patient’s tumor cells respond under controlled laboratory conditions.
Comprehensive Genomic Profiling (NGS)
Utilizing leading NGS platforms, we decode the molecular blueprint of cancer at high resolution. Our profiling identifies actionable mutations, copy number variations, and global biomarkers like TMB and MSI. This data-driven approach maps the oncogenic drivers and resistance signatures that define the precise architecture of the disease.
Single-Cell Profiling
It provides cellular-resolution insights into tumour heterogeneity and immune microenvironment, complementing organoids and NGS. This deep molecular characterization allows us to observe individual cell behavior and identify rare cell populations that may drive therapeutic resistance.